January 07 2025 GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma View all press releases. Choose your path. By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health. ...

GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3][4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & Fr...

We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. Why invest in GSK?

At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each year receive at least one GSK vaccine. Our vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from RSV, meningitis, shingles, flu, polio and many more.

GSK traces its earliest foundation to London in 1715, with the opening of the Plough Court pharmacy. This makes us the longest continually running British pharmaceutical company. Our heritage archives document the contribution we and our legacy companies have made to the world’s health and our impact on science, industry, culture and the ...

We unite science, technology and talent to get ahead of disease together. We are GSK. Getting ahead of disease is one of the most inspiring challenges there is on the planet. We aim to positively impact the health of 2.5 billion people by the end of the decade.

Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.

4 days ago · Such factors include, but are not limited to, those described under Item 3.D “Risk factors” in GSK’s Annual Report on Form 20-F for 2023, and GSK’s Q4 Results for 2024.

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together. A signal for change. We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.